"Immunooncology 2018 and beyond" supported by Bristol-Myers Squibb
|
|
|
- Eustacia Andrews
- 6 years ago
- Views:
Transcription
1 Tuesday, 15 May :00-09:30 Foyer Registration and Welcome Coffee 09:30-10:00 Congress Hall Welcome Address CIMT President Christoph Huber 09:30-10:00 10:00-11:30 Congress Hall Cellular Therapy Chair: Michael Kalos (The Janssen Pharmaceutical Companies, Spring House, PA, United States) Chair: Harpreet Singh (Immatics Biotechnologies, Houston, United States) New modes of T-cell cancer recognition by dissection of immunotherapy successes Speaker: Andrew Sewell (Cardiff University, Cardiff, United Kingdom) ADAPting to solid tumors, advances and challenges for TCR T-cell therapy Speaker: Gwen Binder-Scholl (Adaptimmune, Philadelphia, United States) TIL therapy in melanoma: history of clinical development, current status and plans for the future Speaker: Rodabe Amaria (University of Texas MD Anderson Cancer Center, Houston, United States) 10:00-10:30 10:30-11:00 11:00-11:30 11:30-13:30 Foyer Lunch Corporate Supported Symposium 12:00-13:00 Congress Hall "Immunooncology 2018 and beyond" supported by Bristol-Myers Squibb Chair: Dirk Jäger (National Center for Tumor Diseases, Heidelberg, Germany) Page 1 / 6
2 Immunooncology from mono- to combination therapy - a clinical perspective Speaker: Viktor Grünwald (Hanover, Germany) Resistance to Immunotherapy Speaker: Guy Ungerechts (National Center for Tumor Diseases, Heidelberg, Germany) Biomarkers in Immunooncology - can we predict the outcome of therapy? Speaker: Andreas Jung (Ludwig-Maximilians-Universität, Munich, Germany) 12:00-12:20 12:20-12:40 12:40-13:00 13:30-15:00 Congress Hall Counteracting Immune Escape Chair: Cornelis Melief (ISA Pharmaceuticals, Leiden, Netherlands) Chair: Thorbald van Hall (Leiden University Medical Center, Leiden, Netherlands) TNFR family members and cancer immunotherapy: lessons from chronic infection Speaker: Tania Watts (University of Toronto, Toronto, Canada) title of talk to be announced Speaker: Melody Swartz (University of Chicago, Chicago, United States) Regulation of dendritic cells in tumors Speaker: Jan P. Böttcher (Technical University Munich, Munich, Germany) 13:30-14:00 14:00-14:30 14:30-15:00 15:00-16:00 Foyer Coffee Poster Session 15:00-18:00 East and West Foyers Poster Session I 18:00-19:00 Congress Hall Keynote Lecture Chair: Christoph Huber (CIMT, Mainz, Germany) Highly multiplex 2D and 3D imaging of the immune system and tumors Speaker: Ronald Germain (NIAD, NIH, Bethesda, United States) 18:00-19:00 Page 2 / 6
3 Wednesday, 16 May :00-09:30 Congress Hall Tumor Microenvironment Chair: Viktor Umansky (German Cancer Research Center DKFZ, Heidelberg, Germany) Potent and durable tumor immunity induced by ADU-S100, a first-in-class STING agonist Speaker: Andrea van Elsas (Aduro Biotech, Oss, Netherlands) The Ying and Yang of TAM: Macrophages as effector cells for cytotoxic antibodies in vivo Speaker: Falk Nimmerjahn (Friedrich-Alexander-University, Erlangen, Germany) Myelopoiesis and cancer: "Flipping" over monocytes into immune suppressive cells Speaker: Vincenzo Bronte (University of Verona, Verona, Italy) 08:00-08:30 08:30-09:00 09:00-09:30 09:30-10:00 Foyer Coffee Short Talk Session 10:00-11:30 Gutenberg Hall Short Talk Session I, II, III 11:30-14:00 Foyer Lunch 12:00-13:30 Congress Hall CAR T-Cell Therapy organized by CARAT Chimeric antigen receptor T cells: advances in cellular engineering and clinical development Speaker: Bruce Levine (University of Pennsylvania, Philadelphia, United States) 'T-cell engineering for cancer applications Speaker: Martin Pule (University College London, London, United Kingdom) Cell therapy between academic research and company driven drug development Speaker: Peter Borchmann (University Hospital of Cologne, Cologne, Germany) 12:00-12:30 12:30-13:00 13:00-13:30 Page 3 / 6
4 14:00-15:30 Congress Hall Combination Therapies Chair: Sjoerd H. van der Burg (Leiden Univesrity Medical Center, Leiden, Netherlands) Chair: Dirk Jäger (National Center for Tumor Diseases, Heidelberg, Germany) Stromal Activation in Cancer Immunology and Immunotherapy Speaker: Shannon Turley (Genentech, San Francisco, United States) Mechanistic insights into the immune adjuvant effect of radiotherapy Speaker: Sandra Demaria (Weill Cornell Medicine, New York, United States) The Anti-TGFβ Neutralizing Antibody, SAR439459, Blocks Immunosuppression and Exhibits Anti-tumor Activity in Combination with anti-pd1 Speaker: Jack Pollard (Sanofi Oncology, Cambridge, United States) 14:00-14:30 14:30-15:00 15:00-15:30 15:30-16:30 Foyer Coffee Poster Session 15:30-18:30 East and West Foyers Poster Session II CIMT Members Meeting 17:30-19:00 Dijon Room General Members Assembly of the Association for Cancer Immunotherapy CIMT 19:30-24:00 Foyer Social Event & Poster Award Ceremony Page 4 / 6
5 Thursday, 17 May :30-10:00 Congress Hall Immunoguiding Chair: Marij J.P. Welters (Leiden University Medical Center, Leiden, Netherlands) Chair: Sine Reker Hadrup (Technical University of Denmark, Copenhagen, Denmark) Reprogramming the tumor microenvironment for efficient cancer immunotherapy Speaker: Günter J. Hämmerling (German Cancer Research Center DKFZ, Heidelberg, Germany) Complement in cancer: untangling an intricate relationship Speaker: Dimitrios Mastellos (National Center for Scientific Research 'Demokritos', Athens, Greece) Lung cancer evolution and immune escape Speaker: Nicholas McGranahan (Cancer Research UK Lung Cancer Centre of Excellence, London, United Kingdom) 08:30-09:00 09:00-09:30 09:30-10:00 10:00-10:30 Foyer Coffee 10:30-12:30 Congress Hall Regulatory Research organized by CIMT-RRG and CARAT Chair: Ulrich Kalinke (TWINCORE, Hanover, Germany) Chair: Christian Buchholz (Paul-Ehrlich-Institut, Langen, Germany) Chimeric antigen receptor (CAT) modified T cells - EU regulatory considerations Speaker: Martina Schüssler-Lenz (Committee for Advanced Therapies (CAT), European Medicines Agency, London, United Kingdom) Translation of CAR-based innovations into clinics: how to overcome the regulatory hurdles Speaker: Bernd Schröder (Miltenyi Biotech, Teterow, Germany) From Karl Landsteiner to CAR-T Cells: from processes to products and patients Speaker: Martin Hildebrandt (Technical University Munich, Munich, Germany) 10:30-11:10 11:10-11:50 11:50-12:30 Short Talk Session 10:30-13:00 Gutenberg Hall Short Talk Session IV, V, VI, VII Page 5 / 6
6 Powered by TCPDF ( 13:00-14:00 Foyer Lunch 14:00-15:30 Congress Hall Therapeutic Vaccination Dendritic cell-based vaccination against cancer Speaker: Jolanda de Vries (Radboud University, Nijmegen, Netherlands) Personalized RNA vaccines Speaker: Özlem Türeci (German Cluster of Individualized Immunointervention (CI3), Mainz, Germany) Therapeutic cancer vaccine for combination with immune checkpoint blockade therapy: formulation matters Speaker: Yared Hailemichael (MD Anderson Cancer Center, Houston, United States) 14:00-14:30 14:30-15:00 15:00-15:30 Page 6 / 6
Immunoreceptors and Immunotherapy
Immunoreceptors and Immunotherapy June 10-15, 2018 Snowmass, Colorado Co-Organizers: E. Sally Ward Texas A&M University Health Science Center Texas, USA Stephen A. Beers University of Southampton Southampton,
ESMO Symposium on Immuno-Oncology Programme book
IMMUNO-ONCOLOGY SYMPOSIUM ESMO Symposium on Immuno-Oncology Programme book Advances in cancer immunotherapy; From vaccines to antibodies and cell therapies Geneva Switzerland 15-16 NOVEMBER 2013 esmo.org
6:00 p.m.-8:00 p.m. OPENING KEYNOTE ADDRESSES AND SPECIAL LECTURE Salons EF
Sunday, October 1 6:00 p.m.-8:00 p.m. OPENING KEYNOTE ADDRESSES AND SPECIAL LECTURE 6:00 p.m.-6:45 p.m. Principles of response and resistance to immunotherapy Levi A. Garraway, Eli Lilly and Company, Indianapolis,
Future of Research Research of the Future. Programme
FAU s 275 th Anniversary Symposium Future of Research Research of the Future Programme Our anniversary partners: Cooperation Partner ZiWiS (Center for Applied Philosophy of Science and Key Qualifications)
FEBS 2019 Advanced Lecture Course. Biological Surfaces and Interfaces: The Mechanistic View.
FEBS 2019 Advanced Lecture Course Biological Surfaces and Interfaces: The Mechanistic View. June 30 July 5, 2019 Hotel Eden Roc Sant Feliu de Guixols, Spain Preliminary Program Chair Marta Bally Umeå University
Immunotherapy of cancer: present status and future promise : Danish Cancer Society Symposium, Copenhagen, Denmark, 23rd 25th September 2013
DOI 10.1007/s00262-014-1585-0 Meeting Report Immunotherapy of cancer: present status and future promise : Danish Cancer Society Symposium, Copenhagen, Denmark, 23rd 25th September 2013 Marco Donia Rikke
CRC 992 Symposium on Medical Epigenetics 2018
CRC 992 Symposium on Medical Epigenetics 2018 Monday, March 12 th Wednesday, March 14 th Agenda Lecture Hall Otto-Krayer-Haus Albertstr. 25 79104 Freiburg, Germany Day 1 Monday, March 12 th 2018, 14:30-19:30
Immune Checkpoints in the Tumor Environment:
Immune Checkpoints in the Tumor Environment: Novel Targets and the Clinical Promise of Combined Immunotherapies Monday, 28 October 2013 07.00 08.00 (AM) Parkside Ballroom B, Convention Centre Level 1 Phosphatidylserine
Hinterzartener Kreis der DFG für Krebsforschung. From Molecular Mechanisms to Cancer Therapy
Hinterzartener Kreis der DFG für Krebsforschung From Molecular Mechanisms to Cancer Therapy March 23 - March 26, 2017 Villa La Collina Cadenabbia (Co), Italy Program Committee Andreas Neubauer, Marburg
16 TH -17 TH INNOVATIONS IN ONCOLOGY NOVEMBER HEIDELBERG
16 TH -17 TH 2015 NOVEMBER INNOVATIONS IN ONCOLOGY HEIDELBERG INNOVATIONS IN ONCOLOGY HEIDELBERG, NOVEMBER 16 TH - 17 TH 2015 German Cancer Research Center (DKFZ) Heidelberg - Germany Hosted by the National
27-28 November, 2017 Paris, France Espace Saint-Martin
27-28 November, 2017 Paris, France Espace Saint-Martin 199 bis rue Saint-Martin, 75003 Paris Immuno-oncology research and the subsequent development of immunotherapies continue to progress rapidly. We
Antibodies & Complement Conference May 20-25, 2019
Antibodies & Complement Conference May 20-25, 2019 Preliminary Program Monday, May 20, 2019 14:00 Registration 16:30 Welcome & Introductions Antibodies & Complement I 16:40 Michael Carroll, Harvard Medical
Paediatric strategy forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients
22 August 2018 EMA/242738/2018 Paediatric strategy forum for medicinal product development of checkpoint inhibitors for use in combination therapy in paediatric patients 5-6 September 2018 30 Churchill
:00-13:00 Industry Satellite Symposium 1 Room A. 13:00-13:30 Welcome reception Hall 1. 13:30-13:45 Opening and welcome Room B
04-10-2019 12:00-13:00 Industry Satellite Symposium 1 Room A 13:00-13:30 Welcome reception Hall 1 13:30-13:45 Opening and welcome Room B 13:45-14:15 HHH Award lecture Room B 13:45-14:15 HHH Award lecture
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 2-5, 2013 Villa La Collina Cadenabbia (Co), Italy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Cancer Therapy May 2-5, 2013 Villa La Collina Cadenabbia (Co), Italy Program Committee Martin Schuler, Essen (Chair) Cathrin Brisken,
CNIO- la Caixa Foundation Frontiers Meeting- 2nd-4th MAY 2017 MOLECULAR CHAPERONES IN CANCER
Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain Chairpersons and organizing committee: Nabil Djouder, Spanish National Cancer Research Centre, Madrid, Spain Wilhelm Krek, Institute
Fourth Symposium on Phospholipids in Pharmaceutical Research. 21 st 22 nd, September 2015 Heidelberg, Germany. 3rd Circular
Fourth Symposium on Phospholipids in Pharmaceutical Research 21 st 22 nd, September 2015 Heidelberg, Germany 3rd Circular page 2 Introduction Phospholipids excipients are worldwide being used in many registered
Releasing the Brakes on Tumor Immunity: Immune Checkpoint Blockade Strategies
Releasing the Brakes on Tumor Immunity: Immune Checkpoint Blockade Strategies Jason Muhitch, PhD MIR 509 October 1 st, 2014 Email: jason.muhitch@roswellpark.org 0 Holy Grail of Tumor Immunity Exquisite
IMMUNOTHERAPY FOR CANCER A NEW HORIZON. Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust
IMMUNOTHERAPY FOR CANCER A NEW HORIZON Ekaterini Boleti MD, PhD, FRCP Consultant in Medical Oncology Royal Free London NHS Foundation Trust ASCO Names Advance of the Year: Cancer Immunotherapy No recent
Dirk Heinz, Helmholtz Centre for Infection Research, Germany SESSION I: INDIVIDUALIZED MEDICINE TODAY AND TOMORROW
PRELIMINARY PROGRAM (all academic titles have been omitted) Thursday, June 21, 2018 3.30 p.m. Start of the conference OPENING ADDRESSES Wilhelm Krull, Volkswagen Foundation, Germany Christopher Baum, Medical
Thursday 02 February 2017
Programme Thursday 02 February 2017 12:00-13:30 Arrival / Registration with light refreshments ATC Reception and Foyer 13:30-13:45 Opening remarks 13:45-17:30 Session 1: Unleashing endogenous immunity
Immuno-Oncology Clinical Trials Update: Therapeutic Anti-Cancer Vaccines Issue 7 April 2017
Delivering a Competitive Intelligence Advantage Immuno-Oncology Clinical Trials Update: Therapeutic Anti-Cancer Vaccines Issue 7 April 2017 Immuno-Oncology CLINICAL TRIALS UPDATE The goal of this MONTHLY
Brian Brewer Cancer Research Institute WELCOME
Brian Brewer Cancer Research Institute WELCOME Our Sponsors This event is made possible with generous support from: Our Educational Partners Thank you to those who helped promote the summit Addario Lung
Immuno-Oncology: Perspectives on Current Therapies & Future Developments
Transcript Details This is a transcript of an educational program accessible on the ReachMD network. Details about the program and additional media formats for the program are accessible by visiting: https://reachmd.com/programs/medical-industry-feature/immuno-oncology-perspectives-currenttherapies-future-developments/9502/
DFG. DFG Hinterzartener Kreis für Krebsforschung. From Molecular Mechanisms to Cancer Therapy. May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy
DFG Hinterzartener Kreis für Krebsforschung From Molecular Mechanisms to Cancer Therapy May 15-18, 2014 Villa La Collina Cadenabbia (Co), Italy Program Committee Ursula Klingmüller, Heidelberg (Chair)
More cancer patients are being treated with immunotherapy, but
Bristol-Myers Squibb and Five Prime Present Phase 1a/1b Data Evaluating Cabiralizumab (anti-csf-1 receptor antibody) with Opdivo (nivolumab) in Patients with Advanced Solid Tumors PRINCETON, N.J. & SOUTH
VENUE. NMI Natural and Medical Sciences Institute at the University of Tübingen. Markwiesenstrasse 55, Reutlingen, Germany
VENUE NMI Natural and Medical Sciences Institute at the University of Tübingen Markwiesenstrasse 55, 72770 Reutlingen, Germany GPS-Coordinate: 48 29 38.24 N 9 08 02.73 O AGENDA Get updated about latest
SCIENTIFIC TIMETABLE SIOP 2015
SCIENTIFIC TIMETABLE SIOP 2015 September, 2015 WEDNESDAY, 7 TH OCTOBER 2015 / DAY 2 1.43 09:30 SIOP Committee 12:00 SIOP Essential Drugs Working 13:00 SIOP Work (Open) 14:00 Nurse Researchers 16:00 17:00
Developing Novel Immunotherapeutic Cancer Treatments for Clinical Use
Developing Novel Immunotherapeutic Cancer Treatments for Clinical Use Oncology for Scientists March 8 th, 2016 Jason Muhitch, PhD Assistant Professor Department of Urology Email: jason.muhitch@roswellpark.org
Venue: Spanish National Cancer Research Centre CNIO Auditorium, Madrid, Spain. Chairpersons and organizing committee:
Venue: Spanish National Cancer Research Centre CNIO Auditorium, Chairpersons and organizing committee: Victoria Aranda, Senior Editor, Nature, New York, US Nabil Djouder, Growth Factors, Nutrients and
Dirk Heinz, Helmholtz Centre for Infection Research, Germany SESSION I: INDIVIDUALIZED MEDICINE TODAY AND TOMORROW
PRELIMINARY PROGRAM (all academic titles have been omitted) Thursday, June 21, 2018 3.30 p.m. Start of the conference OPENING ADDRESSES Wilhelm Krull, Volkswagen Foundation, Germany Christopher Baum, Medical
Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies. Michael A. Curran, Ph.D.
Understanding Checkpoint Inhibitors: Approved Agents, Drugs in Development and Combination Strategies Michael A. Curran, Ph.D. MD Anderson Cancer Center Department of Immunology Disclosures I have research
17:00 17:45 Meet-the-Professor Immuno-Oncology Fan Yang, Beijing, Christoph Zielinski, Vienna
8 th Chinese German Lung Cancer Forum Dresden, Germany, September 8-10, 2016 Precision oncology in lung cancer Thursday, September 8, 2016 17:00 17:45 Meet-the-Professor Immuno-Oncology Fan Yang, Beijing,
Emerging Data on the Role of Wnt Biology in Cancer
MEETING AGENDA Emerging Data on the Role of Wnt Biology in Cancer The Banbury Center, Cold Spring Harbor Laboratory, New York, USA October 7-10, 2018 This meeting was funded by Leap Therapeutics Lead Organizers:
Development of Paediatric Medicines: From Learning to Adapting
Preliminary Programme Joint EFGCP / DIA / EMA Medicines for Children Conference on Development of Paediatric Medicines: From Learning to Adapting 26 & 27 September 2012 De Vere Venues Canary Wharf, London,
TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019
KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 26, 2019
International Hepatitis Symposium Heidelberg
16 th May 18 th May 2018 International Hepatitis Symposium Heidelberg Ralf Bartenschlager s 60 th Birthday Symposium (16 th ) AND International Symposium of the TRR179 (17 th to 18 th ) Confirmed Speakers:
TUESDAY, MARCH 26, 2019 WEDNESDAY, MARCH 27, 2019
KEY: PRE CONFERENCE SYMPOSIUM SPONSORED SYMPOSIUM SYMPOSIUM PLENARY LECTURE FORUM OTHER EVENT *PRE-REGISTRATION IS REQUIRED FOR THE INFORMAL NETWORKING WITH PROFESSOR LUNCH SESSION TUESDAY, MARCH 26, 2019
Posters and Presentations
Posters and Presentations June 2017: American Society of Clinical Oncology (ASCO) Annual - Preliminary Correlative Analysis of PD-L1 expression from the SUNRISE Study. View April 2017: American Association
Invited Journal: Nature Medicine. Sponsors: Thermo Fisher Novocure Merck. Venue: Spanish National Cancer Research Centre CNIO Auditorium Madrid, Spain
CNIO Frontiers Meetings Primary and Secondary Brain Tumors 19th-22nd February 2017 Organisers: Richard Gilbertson CRUK Cambridge Institute, UK Michael Weller University Hospital Zurich, Switzerland Massimo
PROGRAM. Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada
Thursday, May 4 Educational Session: Genomics 15:00-17:00 Session Chair: Lillian L. Siu, Princess Margaret Cancer Centre, Toronto, ON, Canada Molecular Tumor Board - Case Presentation Lillian L. Siu, Patricio
6:00 p.m.-7:00 p.m. Opening Keynote Address Salons EF
THURSDAY, OCTOBER 20 6:00 p.m.-7:00 p.m. Opening Keynote Address 6:00 p.m.-7:00 p.m. Title to be announced Tyler Jacks, David H. Koch Institute for Integrative Cancer Research at MIT, Cambridge, MA 7:00
Decision Making Across the Lifespan
40th Annual Meeting EXHIBIT AND SPONSORSHIP October 14-17, 2018 Fairmont The Queen Elizabeth Montreal, QC, Canada Decision Making Across the Lifespan 2018 OCTOBER 14th - 17th SMDM 390 Amwell Road, Suite
against Cancer 55 th HEIDELBERG GRAND ROUNDS Chairs: Prof. Dr. Christof von Kalle Prof. Dr. Dirk Jäger Prof. Dr. Peter Krammer
55 th HEIDELBERG GRAND ROUNDS BIG SHOTS against Cancer Chairs: Prof. Dr. Christof von Kalle Prof. Dr. Dirk Jäger Prof. Dr. Peter Krammer October 25 th, 2016 16.00 18.00 Lecture Hall, DKFZ Communication
Atherosclerosis Mechanisms and novel therapeutic targets International Symposium
Atherosclerosis Mechanisms and novel therapeutic targets International Symposium October 5-6, 2016 Carl Friedrich von Siemens Foundation Nymphenburg Palace, Munich Generously supported by: Wednesday, 05.10.2016
FIFTH WORKSHOP CLINICAL AND IMMUNOLOGICAL ASPECTS OF VACCINOLOGY PROCEEDINGS. 8 th -12 th October 2018 Haunersche Kinderklinik - Munich, Germany
FIFTH WORKSHOP CLINICAL AND IMMUNOLOGICAL ASPECTS OF VACCINOLOGY 8 th -12 th October 2018 Haunersche Kinderklinik - Munich, Germany PROCEEDINGS Organization and Graphic project by: INTRODUCTION GLYCOVAX
TUESDAY, 18th OCTOBER, 2016 / DAY -2
Legend: Keynote Educational PODC Symposium Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite Symposium SIOPe GA SIOP ABM Late
GBS 2018 Frankfurt Congress Program
GBS 2018 Frankfurt Congress Program Monday, September 17th 2018 08:30 17:00 On-site registration, Theodor-Stern-Kai 7, 60590 Frankfurt am Main GBS Young Investigators Session Chairs: Julia Hess (Munich)
Link and Lead A look in the future and the role of transplant coordinators.
TRANSPLANTATION LEARNING JOURNEY Munich, Germany 6-10 2018 Second announcement 6-7 10 th ELITA 6-7 VCA 7 3 rd ETAHP 7-8 27 th 27 th Congress 3 rd Congress & Workshops Workshops 8 9-10 3 rd 9-10 Link and
Are Immune Modulators Really Needed to Cure HBV infection?
Are Immune Modulators Really Needed to Cure HBV infection? Harry L.A. Janssen Francis Family Chair of Hepatology Director Toronto Centre for Liver Disease University Health Network University of Toronto,
CLINICAL APPLICATION OF CAR T CELLS
Memorial Sloan Kettering Cancer Center is pleased to announce CLINICAL APPLICATION OF CAR T CELLS MARCH 10-11, 2016 Conference Location: Memorial Sloan Kettering Cancer Center Zuckerman Research Center
Ludwig Presence at 2017 Society for Immunotherapy of Cancer (SITC) Annual Meeting
Ludwig Scientist(s) Affiliation(s) Keywords Abstract/Presentation Category Presentation/Abstract Title & Time FRIDAY, NOVEMBER 10 Arlene Sharpe (session chair) Ludwig Harvard N/A Science Behind the Therapy:
Masterclass on Clinical Research: How to design a clinical trial
Masterclass on Clinical Research: How to design a clinical trial DAY 1 (Tuesday, 5 March 2013) - Core skills for clinical research 09:30-10:30 Registration and Coffee 10:30 10:35 Welcome Rupert Pearse
Residual Cancer. May 3-5, International Symposium. on Minimal. Le Corum. > Preliminary. Program MONTPELLIER, FRANCE
International Symposium th on Minimal Residual Cancer > Preliminary Program May 3-5, 2018 Le Corum MONTPELLIER, FRANCE Organizers: www.ismrc2018.com > Committee & Speakers > Welcome to Montpellier Scientific
"Development and Clinical Progress. of DNA Vaccines" Program
Paul-Ehrlich-Institut International Conference "Development and Clinical Progress of DNA Vaccines" Paul-Ehrlich-Institut, Langen, Germany October 6-8, 1999 Program CBER/FDA INTERNATIONAL ASSOCIATION FOR
Update on public hearing
Update on public hearing PCWP/HCPWP joint meeting Presented by Juan Garcia Burgos on 0 September 017 Head of Public Engagement Department An agency of the European Union A public hearing provides An opportunity
Melanoma Research Alliance-Pfizer Academic-Industry Partnership Awards
Melanoma Research Alliance-Pfizer Academic-Industry Partnership Awards Wendy K.D. Selig, President & CEO, MRA Julia Perkins, M.D. Medical Director, Oncology, Pfizer Melanoma Research Alliance Mission:
EAS Congress Innsbruck Highlights: A programme to excite, inspire and inform!
Press release 84 th European Atherosclerosis Society Congress, Innsbruck, Austria For circulation 29 th May, 2016. 84 th Annual Congress of the European Atherosclerosis Society (EAS) May 29 th - June 1
31 st Annual Meeting Chicago 2018 Preliminary Program
June 20 June 22, 2019 Northwestern University, Chicago, Illinois USA 15:00-18:00 SLTBR Board Meeting 31 st Annual Meeting Chicago 2018 Preliminary Program Wednesday, June 19 th 8:30-9:00 Registration Thursday,
Immunology and Immunotherapy 101 for the Non-Immunologist
Immunology and Immunotherapy 101 for the Non-Immunologist Stephen P. Schoenberger, Ph.D La Jolla Institute for Allergy and Immunology & UCSD Moores Cancer Center Disclosures Human Longevity Inc: Salary
This meeting has been made possible by an independent grant from Roche.
This meeting has been made possible by an independent grant from Roche. This event has been created in collaboration between the University of Milan and ecancer. MILAN SUMMIT ON PRECISION MEDICINE AGENDA
TUESDAY, 18th OCTOBER, 2016 / DAY -2. THE SPENCER HOTEL Hall A Hall B (St. Lukes Hospital)
Legend: Keynote Educational Meet the Expert (MTE) Paediatric Psycho-Oncology () Opening/Closing Award Session Free Paper Session (FPS) Session Satellite SIOPe GA SIOP ABM Late Breaker Session Networking
Preliminary Programme Version 9 September 2010 EFGCP Children s Medicines Working Party 6th Annual Conference & DIA Paediatric SIAC 4th Forum Current & Future Perspectives for Paediatric Medicines: Visions,
Final Programme EFGCP Children s Medicines Working Party 6th Annual Conference & DIA Paediatric SIAC 4th Forum Current & Future Perspectives for Paediatric Medicines: Visions, Daily Challenges, Ways Forward
Draft Programme Thursday 6 th Friday 7 th September
Draft Programme Thursday 6 th Friday 7 th September Thursday 6th September 08.30 09.45 Registration and Coffee Main Foyer 09.45 10.15 Welcome address Dr Simon Williams, ASO Chair & Professor David Burn,
31 st Annual Meeting Chicago 2019 Preliminary Program V18
June 20 June 22, 2019 Northwestern University, Chicago, Illinois USA 31 st Annual Meeting Chicago 2019 Preliminary Program V18 Wednesday, June 19 th 15:00-18:00 SLTBR Board Meeting Thursday, June 20 th
Conference Programme
Conference Programme From Nutraceuticals to Pharmaceuticals Common Challenges and Approaches Theme 1 Novel sources of nutraceuticals and natural product pharmaceuticals Theme 2 Bioavailability/pharmacokinetics
Cancer Diagnosis and Treatment August 02-03, 2018 Oslo, Norway
Tentative Program International Conferences on Cancer Diagnosis and Treatment August 02-03, 2018 Oslo, Norway ***For available SPEAKER SLOTS*** Conference Series llc LTD 47 Churchfield Road, London, W36AY,
2014 KASBP Fall Symposium
2014 KASBP Fall Symposium Hosted by KASBP, Daewoong and Green Cross Preliminary Program Nov. 7 (Friday) Nov. 8 (Saturday), 2014 THE WESTIN GOVERNOR MORRIS 2 Whippany Road Morristown, New Jersey 07960 Korean
October 25-26, Fifth Avenue 3rd Floor New York, NY (USA)
October 25-26, 2018 404 Fifth Avenue 3rd Floor New York, NY 10018 (USA) events@curepsp.org Join CurePSP and the PSP Association for the First International Research Symposium on PSP & CBD at the Royal
8 th course on NON-CODING GENOME February 13-20, 2019 Institut Curie - Training Unit - International Course
Wednesday, February 13 Non-coding genome and pervasive transcription Chairs: Antonin Morillon Sven Diederichs 11.30 12.30 Registration & LUNCH (sandwiches) 12.30 13.00 13.00 14.00 14.00 15.00 Antonin MORILLON
Faculty of Pathology 37th Annual Symposium & Annual General Meeting. Thursday 7 th & Friday 8 th February 2019 Approved for up 8 CPD credits
Faculty of Pathology 37th Annual Symposium & Annual General Meeting Thursday 7 th & Friday 8 th February 2019 Approved for up 8 CPD credits Thursday 7th February 2019 (5 CPD) 9.30-10:00 Registration /
2006 FASEB Summer Research Conferences FASEB Summer Research Conference in Transplant Immunology June 3-8, 2006 Snowmass Village, Colorado
3/6/06 2006 FASEB Summer Research Conferences FASEB Summer Research Conference in Transplant Immunology June 3-8, 2006 Snowmass Village, Colorado Co-organizers: Fadi G. Lakkis, MD University of Pittsburgh
Faculty of Pathology 37th Annual Symposium & Annual General Meeting. Thursday 7 th & Friday 8 th February 2019 Approved for up to 8 CPD credits
Faculty of Pathology 37th Annual Symposium & Annual General Meeting Thursday 7 th & Friday 8 th February 2019 Approved for up to 8 CPD credits Thursday 7th February 2019 (5 CPD) 9.30-10:00 Registration
Immunotherapy for the Treatment of Cancer
Immunotherapy for the Treatment of Cancer Jason Muhitch, PhD Assistant Professor Department of Urology Department of Immunology Roswell Park Comprehensive Cancer Center Oncology for Scientists March 15,
Low Dose Effects and Non-monotonic Dose Responses for Endocrine Active Chemicals: Science to Practice Workshop
Low Dose Effects and Non-monotonic Dose Responses for Endocrine Active Chemicals: Science to Practice Workshop Agenda Tuesday, September 11 Thursday, September 13, 2012 Charité Medical University of Berlin,
World Rowing Sports Medicine and Science Conference 2018 Berlin, Germany November 21-23, Hall DÖBLIN I+II Einstein I+II Ehrlich I +II Foyer
PROGRAM Wednesday, November 21 st 2018 Congress Overview Hall DÖBLIN I+II Einstein I+II Ehrlich I +II Foyer 14:00 Welcome Session 15:00 Metabolic stress and nutrition Development 16:00 Break 17:00 Understand
Endogenous and Exogenous Vaccination in the Context of Immunologic Checkpoint Blockade
Endogenous and Exogenous Vaccination in the Context of Immunologic Checkpoint Blockade Jedd Wolchok Ludwig Center for Cancer Immunotherapy Memorial Sloan-Kettering Cancer Center MEMORIAL SLOAN- KETTERING
Registration Continental Breakfast. Histone Modifications and Cancer- Part 1
Miami Epigenetics & Cancer Symposium Sunday, November 27 Tuesday, November 29, 2016 Ritz-Carlton, Miami Beach Conference Room: Collins for the Office SPEAKERS PROGRAM Sunday, November 27, 2016 Speakers
Madrid March Manuel Hidalgo. Alberto Bardelli. Lillian Siu. Josep Tabernero. Application deadline February 23 rd
Spanish National Cancer Research Centre CNIO Frontiers Meetings 2015 Madrid 22 25 March 2015 New Trends in Anticancer Drug Development Application deadline February 23 rd Organisers Manuel Hidalgo Alberto
Cancer Biology and Immunology. Sponsorship CANCER BIOLOGY rd World Congress on. Don t count the days make the Days Count
CANCER BIOLOGY 2019 Sponsorship March 11-12, 2019 Milan, Italy 3 rd World Congress on Cancer Biology and Immunology Don t count the days make the Days Count http://cancerbiology.immunologycongress.org/
Immuno-Oncology Clinical Trials Update: Checkpoint Inhibitors Others (not Anti-PD-L1/PD-1) Issue 4 January 2017
Delivering a Competitive Intelligence Advantage Immuno-Oncology Clinical Trials Update: Checkpoint Inhibitors Others (not Anti-PD-L1/PD-1) Issue 4 January 2017 Immuno-Oncology CLINICAL TRIALS UPDATE The
3 rd Berlin Cancer Retreat - Agenda
3 rd Berlin Cancer Retreat - Agenda Wednesday, 5 October 2016 8:30 9:00 Registration 9:00 9:10 Welcome and Introduction Program Exploitation of Oncogenic Mechanisms Ulrike Stein 9:10 9:25 Targeting Myc
ESPACOMP SCIENTIFIC MEETING PROGRAM
ESPACOMP SCIENTIFIC MEETING PROGRAM Meeting venue Altis Grand Hotel Rua Castilho, 11 1269-072 Lisboa Portugal The program is being updated continuously upon confirmation of the speakers THURSDAY 17 NOVEMBER
American Society for Reproductive Immunology 2nd Clinical Reproductive Immunology Symposium
American Society for Reproductive Immunology 2nd Clinical Reproductive Immunology Symposium Using Reproductive Immunology to Improve Clinical Practices Omni New Haven Hotel At Yale, New Haven, Ct, USA
32 nd European NEUROLOGY CONGRESS
conferenceseries.com 32 nd European NEUROLOGY CONGRESS July 22-24, 2019 London, UK SCIENTIFIC PROGRAM conferenceseries.com 32 ND EUROPEAN NEUROLOGY CONGRESS Dear colleague, We are glad to announce the
Fifteenth International Kidney Cancer Symposium
The following presentation should not be regarded as an endorsement of a particular product/drug/technique by the speaker. The presentation topics were assigned to the speakers by the scientific committee
2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme
2016 CRUK Lung Cancer Centre of Excellence Student/Postdoc Winter Workshop Programme Thursday 1 st December 2016 09.15am 10.00am Registration and Refreshments 10.15am 10.30am Welcome 10.30am 11.15am Opening
Transforming patients lives through cellular immunotherapy. Next Generation Cellular Immunotherapy June 2017
Transforming patients lives through cellular immunotherapy Next Generation Cellular Immunotherapy June 2017 1 Overview of Cell Medica Mission: Transform the treatment of cancer with cellular immunotherapy
Tumor Immunity and Immunotherapy. Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School
Tumor Immunity and Immunotherapy Andrew Lichtman M.D., Ph.D. Brigham and Women s Hospital Harvard Medical School Lecture Outline Evidence for tumor immunity Types of tumor antigens Generation of anti-tumor
VIRUSES AND BREAST CANCER
Pisa University Hospital University of Pisa Regione Toscana VIRUSES AND BREAST CANCER INTERNATIONAL WORKSHOP April 2-4, 2012 Palazzo Blu LUNGARNO GAMBACORTI, 9 PISA THE WORKSHOP IS IN THE FRAME OF THE
Cancer Immunotherapy: Active Immunization Approaches
Cancer Immunotherapy: Active Immunization Approaches Willem W. Overwijk, PhD Department of Melanoma Medical Oncology MD Anderson Cancer Center Houston, TX, USA Disclosures No relevant financial relationships
International Society of Microbiota
Targeting Microbiota World Congress 2018 1 Targeting Microbiota World Congress 2018 2 Dear Colleagues, On behalf of the International Society of Microbiota, we are pleased to inform you that the 6th World
European Academy of Paediatrics 2017 Congress and MasterCourse (EAP 2017) Preliminary Programme * As of August 18, Thursday, October 12, 2017
Thursday, October 12, 2017 EAP 2017 MasterCourse Infectious Diseases 08:30-08:45 MasterCourse Welcome & Organizational Introduction Hall A 08:45-11:00 Group 1 11:00-11:30 Coffee Break Group 2 Group 3 MasterCourse
8:30-9:00 Increased dependence on glutamine in PTEN-deficient breast cancer Ramon E. Parsons, Icahn School of Medicine at Mount Sinai, New York, NY
CONFERENCE PROGRAM SATURDAY, OCTOBER 7 3:00 p.m.-7:00 p.m. Salon 3 of the Terrace Welcome and Keynote Lectures 6:00 p.m.-7:30 p.m. Session Chair: Ramon E. Parsons, Icahn School of Medicine at Mount Sinai,
OVARIAN. CANCER Optimal Therapy. Update ADVANCED. 12 th International Symposium. Valencia, 22 nd February
Organized by Valencia, 22 nd February 2019 12 th International Symposium ADVANCED OVARIAN CANCER Optimal Therapy. Update DIRECTORS Andrés Poveda Initia Oncology, Hospital Quirónsalud, Valencia, Spain Jan
The EFGCP Children s Medicines Working Party 3 rd Annual Conference EU Paediatric Regulation: First European Experiences & Strategic Outlook
The EFGCP Children s Medicines Working Party 3 rd Annual Conference EU Paediatric Regulation: First European Experiences & Strategic Outlook 9 October 2007 - Management Centre Europe, Brussels, Belgium
AGENDA: FEBRUARY 22, 2018 INTRODUCTION
FDA-AACR-ASTRO Clinical Development of Drug-Radiotherapy Combinations Workshop with support from Cancer Research UK Combinations Alliance February 22-23, 2018 Bethesda, MD Purpose: There is great interest